A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ehrhardt, Christina ^a   Dudek, Sabine Eva ^a   Holzberg, Magdalena ^a   Urban, Sabine ^a   Hrincius, Eike Roman ^a   Haasbach, Emanuel ^b   Seyer, Roman ^a   Lapuse, Julia ^c   Planz, Oliver ^b   Ludwig, Stephan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Dr Pandalis NatUrprodukte GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK CURRANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG SCREENING; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PLANT LEAF; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INTERFERENCE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOGS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PLANT LEAVES; RIBES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84878133941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063657     Document Type: Article

References (28)

1. Wright PF, Neumann G, Kawaoka Y (2007) Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed. Philadelphia, PA 19106 USA: LIPPINCOTT WILLIAMS & WILKINS, a WOLTERS KLUWER BUSINESS. 1691-1740.
2. Tosh C, Murugkar HV, Nagarajan S, Tripathi S, Katare M, et al. (2011) Emergence of amantadine-resistant avian influenza H5N1 virus in India. Virus Genes 42: 10-15.
3. Puthavathana P, Auewarakul P, Charoenying PC, Sangsiriwut K, Pooruk P, et al. (2005) Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol 86: 423-433.
4. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, et al. (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108.
5. Boltz DA, Douangngeun B, Phommachanh P, Sinthasak S, Mondry R, et al. (2010) Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol 91: 949-959.
6. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, et al. (2012) Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 12: 240-248.
7. Bearman GM, Shankaran S, Elam K, (2010) Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy. Recent Pat Antiinfect Drug Discov 5: 152-156.
8. van der Vries E, Schutten M, Boucher CA, (2011) The potential for multidrug-resistant influenza. Curr Opin Infect Dis 24: 599-604.
9. Daglia M, (2011) Polyphenols as antimicrobial agents. Curr Opin Biotechnol 23: 174-181.
10. Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, et al. (2007) A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res 76: 38-47.
11. Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O, (2007) CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res 76: 1-10.
12. Kalus U, Grigorov A, Kadecki O, Jansen JP, Kiesewetter H, et al. (2009) Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study. Antiviral Res 84: 267-271.
13. Tabart J, Kevers C, Pincemail J, Defraigne JO, Dommes J, (2006) Antioxidant capacity of black currant varies with organ, season, and cultivar. J Agric Food Chem 54: 6271-6276.
14. Knox YM, Suzutani T, Yosida I, Azuma M, (2003) Anti-influenza virus activity of crude extract of Ribes nigrum L. Phytother Res. 17: 120-122.
15. Ikuta K, Hashimoto K, Kaneko H, Mori S, Ohashi K, et al. (2012) Anti-viral and anti-bacterial activities of an extract of the Blackcurrant (Ribes nigrum L.). Microbiol Immunol 56: 805-809.
16. Gopalan A, Reuben SC, Ahmed S, Darvesh AS, Hohmann J, et al. (2012) The health benefits of blackcurrants. Food Funct 3: 795-809.
17. Garbacki N, Tits M, Angenot L, Damas J, (2004) Inhibitory effects of proanthocyanidins from Ribes nigrum leaves on carrageenin acute inflammatory reactions induced in rats. BMC Pharmacol 4: 25.
18. Tabart J, Kevers C, Evers D, Dommes J, (2011) Ascorbic acid, phenolic acid, flavonoid, and carotenoid profiles of selected extracts from Ribes nigrum. J Agric Food Chem 59: 4763-4770.
19. Tits M, Poukens P, Angenot L, Dierckxsens Y, (1992) Thin-layer chromatographic analysis of proanthocyanidins from Ribes nigrum leaves. J Pharm Biomed Anal 10: 1097-1100.
20. Seyer R, Hrincius ER, Ritzel D, Abt M, Mellmann A, et al. (2012) Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis 205: 262-271.
21. Ehrhardt C, Kardinal C, Wurzer WJ, Wolff T, von Eichel-Streiber C, et al. (2004) Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett 567: 230-238.
22. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, et al. (2000) The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97: 12289-12294.
23. Nicholls JM, Chan RW, Russell RJ, Air GM, Peiris JS, (2008) Evolving complexities of influenza virus and its receptors. Trends Microbiol 16: 149-157.
24. Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C, (2010) The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6: e1001099.
25. Eierhoff T, Ludwig S, Ehrhardt C, (2009) The influenza A virus matrix protein as a marker to monitor initial virus internalisation. Biol Chem 390: 509-515.
26. Feld M, Shpacovitch VM, Ehrhardt C, Kerkhoff C, Hollenberg MD, et al. (2008) Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection. J Immunol 180: 6903-6910.
27. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, et al. (2012) PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest. 123: 206-214.
28. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, et al. (2009) Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 182: 7795-7802.